359 related articles for article (PubMed ID: 16162694)
21. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P; Berar-Yanay N; Davidovich A; Magadle R
Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
[TBL] [Abstract][Full Text] [Related]
22. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
Nelson HS; Stricker W; Casale TB; Raff H; Fourré JA; Aron DC; Newman KB
J Clin Pharmacol; 2002 Mar; 42(3):319-26. PubMed ID: 11865969
[TBL] [Abstract][Full Text] [Related]
23. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
[TBL] [Abstract][Full Text] [Related]
24. Fluticasone propionate in children with moderate asthma.
Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
[TBL] [Abstract][Full Text] [Related]
25. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
26. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
Wilson AM; McFarlane LC; Lipworth BJ
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
[TBL] [Abstract][Full Text] [Related]
27. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM
J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
[TBL] [Abstract][Full Text] [Related]
28. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
30. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
[TBL] [Abstract][Full Text] [Related]
31. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
32. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
Wilson AM; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799
[TBL] [Abstract][Full Text] [Related]
33. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
[TBL] [Abstract][Full Text] [Related]
34. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
[TBL] [Abstract][Full Text] [Related]
35. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.
Pearlman DS; Berger WE; Kerwin E; Laforce C; Kundu S; Banerji D
J Allergy Clin Immunol; 2005 Dec; 116(6):1206-12. PubMed ID: 16337447
[TBL] [Abstract][Full Text] [Related]
36. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.
Cavkaytar O; Vuralli D; Arik Yilmaz E; Buyuktiryaki B; Soyer O; Sahiner UM; Kandemir N; Sekerel BE
Eur J Pediatr; 2015 Nov; 174(11):1421-31. PubMed ID: 26255048
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids.
Meltzer EO; Korenblat PE; Weinstein SF; Noonan M; Karafilidis J
Allergy Asthma Proc; 2009; 30(3):293-303. PubMed ID: 19549431
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
39. HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma.
Price J; Lenney W; Duncan C; Green L; Flood Y; Daley-Yates P; Barnacle H; Efthimiou J
Respir Med; 2002 Aug; 96(8):625-31. PubMed ID: 12195844
[TBL] [Abstract][Full Text] [Related]
40. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
